S A Partners Congratulate Shingo Prize Winners AbbVie
S A Partners are delighted to congratulate AbbVie Ballytivnan on winning a Shingo Prize. Niall Kerlin, the operations manager of AbbVie Ballytivnan, popped along to our stand at the Shingo conference, where John Quirke, Partner and Ireland MD, congratulated Niall on their award. Speaking of the award, Niall said:
“Our employees are incredibly proud of this recognition from the Shingo Institute. Using the Shingo Model, we have built a culture of operational excellence by ensuring that our people, systems, and tools are all aligned to our company vision and strategies. The focus on our culture and behaviors has resulted in an engaged and dedicated workforce that is continually improving how we run our business.”
AbbVie is a research-driven biopharmaceutical company with 22 primary research and manufacturing facilities around the world. Their 29,000 employees are scientists, researchers, manufacturing specialists, and regulatory experts located in 170 different markets to treat 30+million patients. AbbVie focuses on coming up with new approaches to address today’s health issues—from life-threatening illness to chronic conditions in the following therapeutic areas of focus: Immunology, Oncology, Neuroscience, Virology, and General Medicine.
AbbVie Ballytivnan currently produces drug delivery devices, including an auto injector pen that is used by patients around the world who use the company’s treatment indicated for a range of immune related illnesses including rheumatoid arthritis and Crohn’s disease. The site also manufactures a combination product that is used to administer a treatment for patients with advanced Parkinson’s disease.